logo
Select company
Select metric
$ -86.19MEarning Before Interest & Taxes (EBIT)
VS
Market
11
Sector
24
Industry
34
History
40
$ 11.01Close
$ 4.26 - $ 15.16 52-Week Range
Ticker Information

Ticker

ENTA

Company Name

ENANTA PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ENANTA PHARMACEUTICALS INC - Earning Before Interest & Taxes (EBIT) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ENTA - EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)
6/30/2025$ -86.19M
3/31/2025$ -90.28M
12/31/2024$ -97M
9/30/2024$ -106.85M
6/30/2024$ -106.61M
3/31/2024$ -118.76M
12/31/2023$ -127.42M
9/30/2023$ -125.85M
6/30/2023$ -125.81M
3/31/2023$ -125.11M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ENANTA PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBIT stands at $ -35.02M.
  • Over the past 5 years, ENANTA PHARMACEUTICALS INC's average EBIT has been $ -105.94M.
  • The median EBIT for ENANTA PHARMACEUTICALS INC during this period was $ -113.17M
  • ENANTA PHARMACEUTICALS INC reached its highest EBIT over the past 5 years at $ -35.02M.
  • The lowest EBIT recorded by ENANTA PHARMACEUTICALS INC in the same timeframe $ -130.54M

ENANTA PHARMACEUTICALS INC's EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT Benchmarks
CompanyEBIT
THTX : THERATECHNOLOGIES INC $ 5.89MBDTX : BLACK DIAMOND THERAPEUTICS INC $ 14.44MPLX : PROTALIX BIOTHERAPEUTICS INC $ 9.18MALEC : ALECTOR INC $ -115.24MSGMO : SANGAMO THERAPEUTICS INC $ -63.5MCSBR : CHAMPIONS ONCOLOGY INC $ 2.87MSPRO : SPERO THERAPEUTICS INC $ -53.6MCCCC : C4 THERAPEUTICS INC $ -111.45MTRDA : ENTRADA THERAPEUTICS INC $ -76.91MCELU : CELULARITY INC $ -65.72M

Definition of Earning Before Interest & Taxes (EBIT)

[Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].

ENTA - Earning Before Interest & Taxes (EBIT), Last 5 years

$ -130.54M

Minimum

Mar 31, 2022

$ -35.02M

Maximum

Sep 30, 2020

$ -105.94M

Average

$ -113.17M

Median

EBIT Benchmark Analysis

The chart above depicts the distribution of EBIT for companies in the Total Stock Market. The average EBIT of the companies is $ 28.62M with a standard deviation of $ 130.62M.
The following table provides additional summary stats:
EBIT in the Market:
filtered constituents3.29K
min$ -402.08M
max$ 442.4M
average$ 28.62M
median$ 897.02K
std$ 130.62M